Schedule 13D ownership disclosure
Adamis Pharmaceuticals Corp
Security class unavailable · CUSIP: 00547W208
Event date: 2014-06-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,715,388
- Percent of class
- 16.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-037909
- Form type
- SC 13D
- Filer
- DMK PHARMACEUTICALS Corp
- CIK
- CIK 887247
- Filed
- Jun 16, 2014
- Reporting period
- Jun 09, 2014
- Description
- Schedule 13D beneficial ownership